- Overview:
- A clinical research study for adolescents and young adults with recently diagnosed type 1 diabetes.
- Staus:
- Enrolling
- Clinical Description:
- This study evaluates the effect of three doses of Diamyd compared to placebo in preserving the body’s insulin production and blood sugar control, in both adolescents and adults recently diagnosed with type 1 diabetes and who carry the HLA DR3-DQ2 haplotypes, and have antibodies against GAD65. For patients who have been diagnosed with type 1 diabetes within the past six months.
- Target Age/Sex:
- 12 up to 29 years old, Male & Female
- Benefits:
- Participants will receive at no cost: study product, study materials, study-specific procedures and diabetes education.
- Study Length:
- 26 Months
- Link:
- ClinicalTrials.gov
- Sponsor Link:
- https://www.diagnode-3.com/
